Zoetis explicitly identifies competition from generic products as a material risk, which typically leads to price erosion and margin compression.
Filing excerpt
Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following: •the possible impact and timing of competing products, including generic alternatives, on our products and our ability to compete against such products;
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
sec-10qpricingPressureGet every 10-Q signal for Zoetis and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Zoetis this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/958ad318-9286-4959-a728-38fb929984a4 returns this record as JSON. POST /v1/companies/enrich returns every signal for zoetis.com.
{
"signal_id": "958ad318-9286-4959-a728-38fb929984a4",
"signal_type": "sec-10q",
"signal_subtype": "pricingPressure",
"detected_at": "2026-08-11T08:09:20.768+00:00",
"company": {
"name": "Zoetis",
"domain": "zoetis.com"
},
"data": {
"detail": "Zoetis explicitly identifies competition from generic products as a material risk, which typically leads to price erosion and margin compression. This creates an urgent need for solutions that improve operational efficiency, reduce costs, or enhance marketing effectiveness to defend market share.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Company highlights significant competitive pressure from generic drug alternatives.",
"excerpts": "Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following: •the possible impact and timing of competing products, including generic alternatives, on our products and our ability to compete against such products;",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1555280/000155528026000040/zts-20260630.htm",
"filing_date": "2026-08-06",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Cost optimization needed",
"signal_category": "market",
"competitors_mentioned": [
"generic alternatives",
"branded and generic competitors"
]
}
}
curl https://signals.autobound.ai/v1/signals/958ad318-9286-4959-a728-38fb929984a4 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"zoetis.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.